ID   KhES-5
AC   CVCL_T798
SY   KHES-5; KhES5
DR   GEO; GSM1040241
DR   GEO; GSM1040311
DR   RCB; HES0005
DR   SKIP; SKIP000156
DR   Wikidata; Q54899881
RX   PubMed=24259714;
RX   PubMed=33059130;
RX   PubMed=33225099;
WW   http://www.nbrp.jp/report/reportProjectEn.jsp?project=esCell
CC   From: Institute for Frontier Medical Sciences, Kyoto University; Kyoto; Japan.
CC   Omics: DNA methylation analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=24259714; DOI=10.1073/pnas.1319061110;
RA   Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H.,
RA   Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N.,
RA   Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J.,
RA   Yamanaka S.;
RT   "Differentiation-defective phenotypes revealed by large-scale analyses
RT   of human pluripotent stem cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013).
//
RX   PubMed=33059130; DOI=10.1016/j.scr.2020.102020;
RA   Kawase E., Takada K., Suemori H.;
RT   "Kyoto hESC cell resource for regenerative medicine.";
RL   Stem Cell Res. 49:102020-102020(2020).
//
RX   PubMed=33225099; DOI=10.31662/jmaj.2018-0029;
RA   Umezawa A., Sato Y., Kusakawa S., Amagase R., Akutsu H., Nakamura K.,
RA   Kasahara M., Matsubara Y., Igarashi T.;
RT   "Research and development strategy for future embryonic stem cell-
RT   based therapy in Japan.";
RL   JMA J. 3:287-294(2020).
//